- Home
- TTI vs CMPX Comparison
TTI vs CMPX Comparison
Compare TTI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- CMPX
- Stock Information
- Founded
- TTI 1981
- CMPX 2014
- Country
- TTI United States
- CMPX United States
- Employees
- TTI N/A
- CMPX N/A
- Industry
- TTI Oil & Gas Production
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- TTI Energy
- CMPX Health Care
- Exchange
- TTI Nasdaq
- CMPX Nasdaq
- Market Cap
- TTI 761.0M
- CMPX 752.4M
- IPO Year
- TTI 1990
- CMPX N/A
- Fundamental
- Price
- TTI $7.70
- CMPX $4.98
- Analyst Decision
- TTI Strong Buy
- CMPX Strong Buy
- Analyst Count
- TTI 3
- CMPX 7
- Target Price
- TTI $7.00
- CMPX $14.43
- AVG Volume (30 Days)
- TTI 2.3M
- CMPX 1.9M
- Earning Date
- TTI 10-28-2025
- CMPX 11-05-2025
- Dividend Yield
- TTI N/A
- CMPX N/A
- EPS Growth
- TTI 7085.43
- CMPX N/A
- EPS
- TTI 0.92
- CMPX N/A
- Revenue
- TTI $618,755,000.00
- CMPX N/A
- Revenue This Year
- TTI $5.57
- CMPX N/A
- Revenue Next Year
- TTI $4.58
- CMPX N/A
- P/E Ratio
- TTI $8.37
- CMPX N/A
- Revenue Growth
- TTI 0.17
- CMPX N/A
- 52 Week Low
- TTI $2.03
- CMPX $1.33
- 52 Week High
- TTI $8.35
- CMPX $5.16
- Technical
- Relative Strength Index (RSI)
- TTI 56.69
- CMPX 69.23
- Support Level
- TTI $7.05
- CMPX $4.79
- Resistance Level
- TTI $7.89
- CMPX $5.11
- Average True Range (ATR)
- TTI 0.51
- CMPX 0.32
- MACD
- TTI -0.08
- CMPX 0.04
- Stochastic Oscillator
- TTI 55.51
- CMPX 89.12
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.